Abbvie Ownership


USD 138.04  0.88  0.63%   

Some institutional investors establish a significant position in stocks such as Abbvie in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Abbvie, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Please continue to Trending Equities.
Dividend Yield is likely to climb to 0.0406 in 2022, whereas Payment of Dividends and Other Cash Distributions is likely to drop (9.5 B) in 2022. Abbvie Weighted Average Shares is fairly stable at the moment as compared to the past year. Abbvie reported Weighted Average Shares of 1.77 Billion in 2021. Weighted Average Shares Diluted is likely to climb to about 1.9 B in 2022, whereas Issuance Purchase of Equity Shares is likely to drop (744.5 M) in 2022.
Abbvie Inc retains a total of 1.77 Billion outstanding shares. The majority of Abbvie Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbvie Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbvie. Please pay attention to any change in the institutional holdings of Abbvie Inc as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Abbvie Stock Ownership Analysis

About 71.0% of the company shares are held by institutions such as insurance companies. The company next dividend is scheduled to be issued on the 14th of July 2022. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 50000 people. For more info on Abbvie Inc please contact Richard Gonzalez at 847 932-7900 or go to
Besides selling stocks to institutional investors, Abbvie also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Abbvie's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Abbvie's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Abbvie Quarterly Share Based Compensation

107 Million

Less than 1% of Abbvie Inc are currently held by insiders. Unlike Abbvie's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Abbvie's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%.

Abbvie SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Abbvie prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Abbvie investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Abbvie Inc specific information freely available to individual and institutional investors to make a timely investment decision.
29th of July 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
28th of June 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
9th of February 2022
Unclassified Corporate Event

Abbvie Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Abbvie is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abbvie Inc backward and forwards among themselves. Abbvie's institutional investor refers to the entity that pools money to purchase Abbvie's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Sumitomo Mitsui Trust Holdings IncCommon Shares5.3 M809.3 M
New York State Common Retirement FundCommon Shares3.5 M534.8 M
Envestnet Asset Management IncCommon Shares3.3 M507.2 M
Truist Financial CorpCommon Shares3.3 M500.3 M
Dekabank Deutsche GirozentraleCommon Shares2.7 M418.4 M
Us BancorpCommon Shares2.6 M396 M
Victory Capital Management IncCommon Shares2.4 M363.5 M
Note, although Abbvie's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Abbvie Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Abbvie insiders, such as employees or executives, is commonly permitted as long as it does not rely on Abbvie's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Abbvie insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Michael Severino over two months ago via Macroaxis 
Exercise or conversion by Michael Severino of 217 shares of Abbvie subject to Rule 16b-3
Henry Gosebruch over two months ago via Macroaxis 
Exercise or conversion by Henry Gosebruch of 83960 shares of Abbvie subject to Rule 16b-3
Henry Gosebruch over two months ago via Macroaxis 
Exercise or conversion by Henry Gosebruch of 83960 shares of Abbvie subject to Rule 16b-3
Carrie Strom over two months ago via Macroaxis 
Payment of 2876 shares by Carrie Strom of Abbvie subject to Rule 16b-3
Michael Severino over two months ago via Macroaxis 
Exercise or conversion by Michael Severino of 29221 shares of Abbvie subject to Rule 16b-3
Carrie Strom over two months ago via Macroaxis 
Payment of 234 shares by Carrie Strom of Abbvie subject to Rule 16b-3
Robert Alpern over three months ago via Macroaxis 
Acquisition by Robert Alpern of tradable shares of Abbvie subject to Rule 16b-3
Jeffrey Stewart over three months ago via Macroaxis 
Exercise or conversion by Jeffrey Stewart of 27690 shares of Abbvie subject to Rule 16b-3
Timothy Richmond over three months ago via Macroaxis 
Acquisition by Timothy Richmond of 22993 shares of Abbvie subject to Rule 16b-3
Brian Durkin over three months ago via Macroaxis 
Exercise or conversion by Brian Durkin of 11682 shares of Abbvie subject to Rule 16b-3
Carrie Strom over three months ago via Macroaxis 
Payment of 355 shares by Carrie Strom of Abbvie subject to Rule 16b-3
Elaine Sorg over three months ago via Macroaxis 
Sale by Elaine Sorg of 700 shares of Abbvie

Abbvie Outstanding Bonds

Abbvie issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Abbvie Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Abbvie bonds can be classified according to their maturity, which is the date when Abbvie Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbvie without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Tickers Now


Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Pair Trading with Abbvie

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbvie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbvie will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Abbvie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbvie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbvie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbvie Inc to buy it.
The correlation of Abbvie is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbvie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbvie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbvie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Abbvie Inc information on this page should be used as a complementary analysis to other Abbvie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Abbvie Stock analysis

When running Abbvie Inc price analysis, check to measure Abbvie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbvie is operating at the current time. Most of Abbvie's value examination focuses on studying past and present price action to predict the probability of Abbvie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbvie's price. Additionally, you may evaluate how the addition of Abbvie to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Abbvie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbvie. If investors know Abbvie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbvie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
244.1 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Abbvie Inc is measured differently than its book value, which is the value of Abbvie that is recorded on the company's balance sheet. Investors also form their own opinion of Abbvie's value that differs from its market value or its book value, called intrinsic value, which is Abbvie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbvie's market value can be influenced by many factors that don't directly affect Abbvie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbvie's value and its price as these two are different measures arrived at by different means. Investors typically determine Abbvie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbvie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.